Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8741693 | Osteoarthritis and Cartilage | 2018 | 32 Pages |
Abstract
Contrary to prior reviews, our analysis showed that bisphosphonates neither provide symptomatic relief nor defer radiographic progression in knee OA. However, these agents may still be beneficial in certain subsets of patients who display high rates of subchondral bone turnover. Future studies should be directed at defining such OA subsets and investigating the effects of bisphosphonates in those patients.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
E.E. Vaysbrot, M.C. Osani, M.-C. Musetti, T.E. McAlindon, R.R. Bannuru,